{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:39:12Z","timestamp":1778711952295,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2320-B-006-045-MY3"],"award-info":[{"award-number":["109-2320-B-006-045-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.pathol.2022.07.007","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T11:39:09Z","timestamp":1662464349000},"page":"94-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"55","author":[{"given":"Yi-sian","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-min","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9487-657X","authenticated-orcid":false,"given":"Yi-ching","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiang-jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-2608","authenticated-orcid":false,"given":"Liang-yi","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6577-8006","authenticated-orcid":false,"given":"L.Jeffrey","family":"medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6748-7448","authenticated-orcid":false,"given":"Ya-ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-shi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9665-5236","authenticated-orcid":false,"given":"Kung-chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2022.07.007_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.pathol.2022.07.007_bib2","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1080\/10428194042000198849","article-title":"Distribution and prognosis of WHO lymphoma subtypes in Taiwan reveals a low incidence of germinal-center derived tumors","volume":"45","author":"Chang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2022.07.007_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2022.07.007_bib4","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00277-014-2116-y","article-title":"Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapy","volume":"93","author":"Carbone","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.pathol.2022.07.007_bib5","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2022.07.007_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2022.07.007_bib7","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.007_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.seminhematol.2015.01.008","article-title":"B-cell receptor signaling in diffuse large B-cell lymphoma","volume":"52","author":"Young","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.pathol.2022.07.007_bib9","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/nm.3943","article-title":"The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development","volume":"21","author":"Ortega-Molina","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2022.07.007_bib10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2022.07.007_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature13765","article-title":"Loss of signalling via Galpha13 in germinal centre B-cell-derived lymphoma","volume":"516","author":"Muppidi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2022.07.007_bib12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nm.4092","article-title":"An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation","volume":"22","author":"Souroullas","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2022.07.007_bib13","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pathol.2022.07.007_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.pathol.2022.07.007_bib15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A\u00a0probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2022.07.007_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/JLB.MR1117-471R","article-title":"IL-20 receptor cytokines in autoimmune diseases","volume":"104","author":"Chen","year":"2018","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.pathol.2022.07.007_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pathol.2022.07.007_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nri3766","article-title":"The IL-20 subfamily of cytokines--from host defence to tissue homeostasis","volume":"14","author":"Rutz","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pathol.2022.07.007_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0092-8674(01)00187-8","article-title":"Interleukin 20: discovery, receptor identification, and role in epidermal function","volume":"104","author":"Blumberg","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.pathol.2022.07.007_bib20","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1523-1747.2003.12626.x","article-title":"Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol","volume":"121","author":"Romer","year":"2003","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pathol.2022.07.007_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.gene.6364291","article-title":"Interleukin-20 promotes angiogenesis in a direct and indirect manner","volume":"7","author":"Hsieh","year":"2006","journal-title":"Genes Immun"},{"key":"10.1016\/j.pathol.2022.07.007_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/srep24339","article-title":"Anti-IL-20 monoclonal antibody promotes bone fracture healing through regulating IL-20-mediated osteoblastogenesis","volume":"6","author":"Hsu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.pathol.2022.07.007_bib23","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4049\/jimmunol.1102843","article-title":"Anti-IL-20 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models","volume":"188","author":"Hsu","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2022.07.007_bib24","article-title":"Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A","volume":"7","author":"Lee","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.pathol.2022.07.007_bib25","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1074\/jbc.M112.410233","article-title":"Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-kappaB) activation by inducing the up-regulation of p21(WAF1) protein expression","volume":"288","author":"Lee","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2022.07.007_bib26","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1038\/s41467-020-18244-8","article-title":"IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models","volume":"11","author":"Lu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2022.07.007_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.2003533","article-title":"Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma","volume":"10","author":"Stirm","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.pathol.2022.07.007_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.007_bib29","first-page":"102","article-title":"NCCN non-Hodgkin's lymphoma practice guidelines panel. NCCN: non-Hodgkin's lymphoma","volume":"8","author":"Zelenetz","year":"2001","journal-title":"Cancer Control"},{"key":"10.1016\/j.pathol.2022.07.007_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/his.12706","article-title":"Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart","volume":"67","author":"Chang","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2022.07.007_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clim.2005.06.012","article-title":"Detection of IL-20 and its receptors on psoriatic skin","volume":"117","author":"Wei","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.pathol.2022.07.007_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humpath.2005.05.003","article-title":"Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype","volume":"36","author":"Chang","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2022.07.007_bib33","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000001076","article-title":"A\u00a0newly recognized histologic pattern of IgG4-related lymphadenopathy: expanding the morphologic spectrum","volume":"42","author":"Chen","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2022.07.007_bib34","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1182\/blood-2010-12-323238","article-title":"Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma","volume":"117","author":"Dojcinov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.007_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78508-7","article-title":"Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma","volume":"10","author":"Chang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.pathol.2022.07.007_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2016.04.001","article-title":"ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB\/TRAF6 complex","volume":"175","author":"Dai","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.pathol.2022.07.007_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40364-021-00330-8","article-title":"Deciphering genes associated with diffuse large B-cell lymphoma with lymphomatous effusions: a mutational accumulation scoring approach","volume":"9","author":"Abdollahi","year":"2021","journal-title":"Biomark Res"},{"key":"10.1016\/j.pathol.2022.07.007_bib38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nbt.3807","article-title":"Prediction of potent shRNAs with a sequential classification algorithm","volume":"35","author":"Pelossof","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pathol.2022.07.007_bib39","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00018-020-03630-8","article-title":"FGF primes angioblast formation by inducing ETV2 and LMO2 via FGFR1\/BRAF\/MEK\/ERK","volume":"78","author":"Chen","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pathol.2022.07.007_bib40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/cas.14833","article-title":"Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: implications for targeted therapy","volume":"112","author":"Lin","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pathol.2022.07.007_bib41","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A\u00a0rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.pathol.2022.07.007_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.pathol.2022.07.007_bib43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/biomet\/52.3-4.650","article-title":"A\u00a0generalized two-sample Wilcoxon test for doubly censored data","volume":"52","author":"Gehan","year":"1965","journal-title":"Biometrika"},{"key":"10.1016\/j.pathol.2022.07.007_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3727\/096368914X678319","article-title":"The therapeutic potential of anti-interleukin-20 monoclonal antibody","volume":"23","author":"Hsu","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.pathol.2022.07.007_bib45","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.4049\/jimmunol.168.11.5397","article-title":"Cutting edge: immune cells as sources and targets of the IL-10 family members?","volume":"168","author":"Wolk","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2022.07.007_bib46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/10428194.2012.717079","article-title":"Interleukin-24 mediates apoptosis in human B-cells through early activation of cell cycle arrest followed by late induction of the mitochondrial apoptosis pathway","volume":"54","author":"Hadife","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.pathol.2022.07.007_bib47","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.4049\/jimmunol.169.8.4288","article-title":"IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha","volume":"169","author":"Liao","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2022.07.007_bib48","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.4049\/jimmunol.181.9.6051","article-title":"IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression","volume":"181","author":"Sainz-Perez","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pathol.2022.07.007_bib49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin-10 and related cytokines and receptors","volume":"22","author":"Pestka","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.pathol.2022.07.007_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-981-13-9367-9_4","article-title":"Interleukin-10 family cytokines immunobiology and structure","volume":"1172","author":"Wei","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pathol.2022.07.007_bib51","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.27189","article-title":"IL-20 and IL-20R1 antibodies protect against liver fibrosis","volume":"60","author":"Chiu","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.07.007_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-981-15-3532-1_4","article-title":"Germinal center reaction","volume":"1254","author":"Huang","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pathol.2022.07.007_bib53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.183.3.971","article-title":"Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2","volume":"183","author":"Martinez-Valdez","year":"1996","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.pathol.2022.07.007_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pathol.2019.09.005","article-title":"Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis","volume":"52","author":"Piris","year":"2020","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2022.07.007_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2567.2006.02392.x","article-title":"A\u00a0distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation","volume":"118","author":"Mansson","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.pathol.2022.07.007_bib56","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.1125703","article-title":"Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells","volume":"312","author":"Qi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.pathol.2022.07.007_bib57","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1182\/blood-2018-03-841015","article-title":"B-cell receptor-mediated NFATc1 activation induces IL-10\/STAT3\/PD-L1 signaling in diffuse large B-cell lymphoma","volume":"132","author":"Li","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2022.07.007_bib58","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1182\/bloodadvances.2021005522","article-title":"Decreased IL-10 accelerates B-cell leukemia\/lymphoma in a mouse model of pediatric lymphoid leukemia","volume":"6","author":"Fitch","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.pathol.2022.07.007_bib59","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41375-020-01088-y","article-title":"A\u00a0novel model of alternative NF-kappaB pathway activation in anaplastic large cell lymphoma","volume":"35","author":"Wang","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2022.07.007_bib60","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1535-6108(04)00084-4","article-title":"The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma","volume":"5","author":"Horie","year":"2004","journal-title":"Cancer Cell"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522002495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522002495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:41:49Z","timestamp":1777434109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302522002495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0031302522002495"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2022.07.007","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of interleukin-20 correlates with favourable prognosis in diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2022.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}